CLINICAL AND TREATMENT CHARACTERISTICS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN EUROPE

被引：0
|
作者：
Oriol, A. [1 ]
Steinmetz, T. [2 ]
Patel, V [3 ]
Kutikova, L. [4 ]
Schmidt, N. [5 ]
Hennies, N. [5 ]
Thiess, A. [5 ]
Kostev, K. [5 ]
Leleu, X. [6 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Inst Catala Oncol, Barcelona, Spain
[2] MVZ Hematol & Oncol Cologne, Cologne, Germany
[3] Amgen Europe GmbH, London, England
[4] Amgen Europe GmbH, Rotkreuz, Switzerland
[5] IQVIA Commercial GmbH & Co OHG, Frankfurt, Germany
[6] CHU Poitiers, Hosp La Miletrie, Poitiers, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN318
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [41] Treatment of relapsed and refractory multiple myeloma
    Engelhardt, M.
    Graziani, G.
    Javorniczky, R.
    Neubauer, J.
    Koehler, M.
    Herget, G. W.
    Waesch, R.
    [J]. ONKOLOGE, 2018, 24 (08): : 613 - 624
  • [42] Treatment of Relapsed/Refractory Multiple Myeloma
    Kastritis, Efstathios
    Palumbo, Antonio
    Dimopoulos, Meletios A.
    [J]. SEMINARS IN HEMATOLOGY, 2009, 46 (02) : 143 - 157
  • [43] Treatment of relapsed or refractory multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    [J]. LEUKEMIA RESEARCH, 2018, 73 : S3 - S3
  • [44] Real World Evaluation of Teclistamab: A Focus on Infections in Patients With Relapsed Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Martin, Thomas
    Wolf, Jeffrey
    Chung, Alfred
    Arora, Shagun
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S536 - S537
  • [45] Relationship of Carfilzomib Dosing and Duration of Therapy (DOT) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)
    Harvey, R. Donald
    Chen, Yaozhu J.
    Lethen, Jan
    Mahue, Maya
    [J]. BLOOD, 2015, 126 (23)
  • [46] Treatment of relapsed and refractory multiple myeloma
    Seema Singhal
    Jayesh Mehta
    [J]. Current Treatment Options in Oncology, 2003, 4 (3) : 229 - 237
  • [47] Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
    Gupta, Vikas A.
    Nooka, Ajay K.
    Lonial, Sagar
    Boise, Lawrence H.
    [J]. BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2013, 3 : 41 - 51
  • [48] Treatment of relapsed and refractory multiple myeloma
    Sonneveld, Pieter
    Broijl, Annemiek
    [J]. HAEMATOLOGICA, 2016, 101 (04) : 396 - 406
  • [49] TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Zamagni, E.
    Tacchetti, P.
    Barbato, S.
    Cavo, M.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 215 - 218
  • [50] Treatment of relapsed and refractory multiple myeloma
    Lee, Ji Hyun
    Kim, Sung-Hyun
    [J]. BLOOD RESEARCH, 2020, 55 : 43 - 53
12345